Single Cell Analysis Market Size, Share, By Product (Consumables and Instruments), Cell Type (Human Cells, Animal Cells, and Others), Technique (Flow Cytometry, NGS, PCR, Microscopy, and Others), Workflow (Single Cell Isolation and Library Preparation, Downstream Analysis, and Data Analysis), Application (Cancer, Immunology, Neurology, Stem Cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization, and Others), End-User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035

• Thermo Fisher Scientific Inc.
• QIAGEN
• Bio-Rad Laboratories, Inc.
• 10x Genomics
• BD
• Illumina, Inc.
• Merck KGaA
• Takara Bio Inc.
• Corning Incorporated
• Novogene Co., Ltd.
• Standard BioTools
• BGI
• BIOMÉRIEUX
• Bruker Cellular Analysis

Recent News:

• Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced the launch of the Parse GigaLab to scale single cell sequencing to billions of cells per year, in October 2024. The GigaLab leveraged Parse’s Evercode single cell technology with a scaled up workflow and expanded automation to enable discoveries never before deemed possible with current single cell approaches.
• BD (Becton, Dickinson and Company), a leading global medical technology company, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits that would enable automation to ensure greater consistency and increased efficiency of large-scale, single-cell discovery studies and analysis, in October 2024.